Medical Condition News

RSS

Elevated blood eosinophil levels find to be risk factor for exacerbations in asthma patients

In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations, according to a new study presented at the 2014 American Thoracic Society International Conference.

21 May 2014

Vitamin E-rich oils may increase incidence of asthma, says study

A large new Northwestern Medicine- study upends our understanding of vitamin E and ties the increasing consumption of supposedly healthy vitamin E-rich oils -- canola, soybean and corn - to the rising incidence of lung inflammation and, possibly, asthma.

21 May 2014

Physical activity may be able to prevent overweight women from developing heart disease

For otherwise healthy middle-aged women who are overweight or obese, physical activity may be their best option for avoiding heart disease, according to a study that followed nearly 900 women for seven years.

21 May 2014

Study: Hearing impairment linked with sleep apnea

Both high and low frequency hearing impairment have been linked with sleep apnea in a new study of nearly 14,000 individuals.

21 May 2014

Isis Pharmaceuticals starts Phase 1 clinical study of ISIS-PKKRx to treat patients with HAE

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it initiated a Phase 1 clinical study of ISIS-PKKRx. ISIS-PKKRx is an antisense drug in development to treat patients with hereditary angioedemia (HAE).

21 May 2014

Substance from pine bark is a potential source for treating melanoma

A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers.

21 May 2014

New antibody can improve quality of life for individuals with asthma

Researchers at St. Joseph's Healthcare Hamilton and McMaster University have successfully tested an antibody that can improve the quality of life for individuals with asthma by relieving inflammation in the lungs.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Study investigates whether use of mobile phones affects children's cognitive development

A new study launching today will investigate whether the use of mobile phones and other wireless technologies might affect children's cognitive development.

21 May 2014

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

Studies have identified mobile phones and related devices as sources of metal sensitization and potential causes of allergic contact dermatitis (ACD).

21 May 2014

New cognitive test determines memory impairments due to AD and normal aging

Researchers have developed a new cognitive test that can better determine whether memory impairments are due to very mild Alzheimer's disease or the normal aging process.

21 May 2014

$15 million pledged for creation of Johns Hopkins Greenberg Bladder Cancer Institute

Baltimore-area commercial real estate developer Erwin L. Greenberg and his wife Stephanie Cooper Greenberg have pledged a $15 million gift to create the Johns Hopkins Greenberg Bladder Cancer Institute.

20 May 2014

Existing pharmaceutical drugs may offer effective therapies against MERS

A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).

20 May 2014

Proteo Biotech, BDC sign deal to develop orphan medicinal product Tiprelestat

Proteo Inc. announced today that its German subsidiary, Proteo Biotech AG, has entered into an agreement with the US company Biotech Development Corp. (BDC).

20 May 2014

New study provides evidence that bacteria in gut may be linked to children with autism

Children with autism spectrum disorders (ASD) have significantly different concentrations of certain bacterial-produced chemicals, called metabolites, in their feces compared to children without ASD.

20 May 2014

SynCardia Total Artificial Heart achieves 1,300th milestone

SynCardia Systems, Inc. announced today that a United States patient with end-stage biventricular heart failure received the 1,300th implant of the SynCardia temporary Total Artificial Heart as a bridge to transplant in April 2014.

20 May 2014

Study reveals surprising relationships between diet and release of hormones that suppress eating

By comparing how gut microbes from human vegetarians and grass-grazing baboons digest different diets, researchers have shown that ancestral human diets, so called "paleo" diets, did not necessarily result in better appetite suppression.

20 May 2014

Novel drug for patients with inoperable CTEPH shows improvement in international trial

After a year of being treated with a novel drug, patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and those with persistent or recurrent pulmonary hypertension after an operation for the disease showed sustained improvement in a multicenter, international trial presented at the 2014 American Thoracic Society International Conference.

20 May 2014

CINVESTAV creates stereoscopic vision lenses for blind to navigate more easily

Combining computational geometry, artificial intelligence, geo and ultrasound techniques, among others, scientists from the Center for Research and Advanced Studies (CINVESTAV) created a device to help people with low vision or blindness to navigate more easily.

20 May 2014

Juventas presents positive trial results of JVS-100 drug delivered by Biocardia’s Helix transendocardial system

BioCardia®, Inc., a leader in cardiovascular regenerative medicine, today announced the presentation by Juventas Therapeutics of their positive four-month results for their STOP-HF Trial.

20 May 2014

Medical Condition News

Elevated blood eosinophil levels find to be risk factor for exacerbations in asthma patients

Vitamin E-rich oils may increase incidence of asthma, says study

Physical activity may be able to prevent overweight women from developing heart disease

Study: Hearing impairment linked with sleep apnea

Isis Pharmaceuticals starts Phase 1 clinical study of ISIS-PKKRx to treat patients with HAE

Substance from pine bark is a potential source for treating melanoma

New antibody can improve quality of life for individuals with asthma

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Study investigates whether use of mobile phones affects children's cognitive development

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

New cognitive test determines memory impairments due to AD and normal aging

$15 million pledged for creation of Johns Hopkins Greenberg Bladder Cancer Institute

Existing pharmaceutical drugs may offer effective therapies against MERS

Proteo Biotech, BDC sign deal to develop orphan medicinal product Tiprelestat

New study provides evidence that bacteria in gut may be linked to children with autism

SynCardia Total Artificial Heart achieves 1,300th milestone

Study reveals surprising relationships between diet and release of hormones that suppress eating

Novel drug for patients with inoperable CTEPH shows improvement in international trial

CINVESTAV creates stereoscopic vision lenses for blind to navigate more easily

Juventas presents positive trial results of JVS-100 drug delivered by Biocardia’s Helix transendocardial system

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News